Brief: CanSino Biologics Swings Prelim 2022 Net Loss Of 901.9 Mln Yuan
Feb 27 (Reuters) - CanSino Biologics Inc
6185.HK 688185.SS :
* SAYS IT SWINGS PRELIM 2022 NET LOSS OF 901.9 MILLION YUAN
($129.55 million) FROM NET PROFIT OF 1.9 BILLION YUAN YEAR
EARLIER
Source text
Further company coverage: 6185.HK
($1 = 6.9620 Chinese yuan renminbi)
(Reporting by Hong Kong newsroom)
((meg.shen@thomsonreuters.com; 852-39525805;))
Recent news on Cansino Biologics
See all newsBrief: CanSino Biologics Says China's NMPA Granted Priority Review Status To NDA For TD5CP Adolescent, Adult
Brief: CanSino Biologics Reports Widened Net Loss For Q1
Brief: CanSino Biologics Says 2025 Net Profit At 27.9 Million Yuan
Brief: CanSino Biologics Prelim 2025 Net Profit At 27.9 Million Yuan
Brief: CanSino Biologics Expects To Have Returned to Net Profit In 2025